LifeStance Health Group, Inc. Form 8-K Summary
Business context and reporting period
LifeStance Health Group, Inc. filed a Form 8-K dated November 8, 2022, under Items 2.02, 7.01, and 9.01. The filing announces operating results for the third quarter ended September 30, 2022, and furnishes supplemental investor information.
Financial metrics
The filing text provided does not include clear values for revenue, net income or loss, cash flow, margins, debt, liquidity, operating expenses, or other financial metrics. The reported results are contained in Exhibit 99.1, the press release, which is referenced but not included in the provided text.
Material changes versus the prior comparable period
The filing text does not provide quantitative or qualitative comparisons with the third quarter of 2021 or any other prior comparable period.
Guidance, outlook, risks, and unusual items
- Exhibit 99.1 contains the company’s third-quarter results announcement.
- Exhibit 99.2 contains a slide presentation with supplemental information.
- The provided filing text does not state guidance, outlook, management commentary, risks, contingencies, or unusual items.
- The information furnished under Items 2.02 and 7.01, including the exhibits, is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings except by specific reference.
Important facts for investors to verify
- Review Exhibit 99.1 for third-quarter revenue, profitability, cash flow, margins, balance-sheet metrics, and management commentary.
- Review Exhibit 99.2 for supplemental operating metrics, outlook, and presentation materials.
- Verify any changes from the prior-year quarter and any updated financial guidance in the exhibits.
- The company’s common stock trades on Nasdaq under the symbol LFST.